Fundraising Fox

Doug Williams

Investor

Biotech Executive & Founding Pillar at Pillar VC

United States

About

Doug Williams has held senior leadership roles across the biotechnology industry, including Executive Vice President of Research and Development at Biogen, CEO of ZymoGenetics (which he led through its acquisition by Bristol Myers Squibb), and Chief Scientific Officer and EVP of R&D at Seattle Genetics. He previously served as Senior Vice President and Washington Site Leader at Amgen and as EVP, Chief Technology Officer, and board member at Immunex. He holds a Ph.D. from the State University of New York at Buffalo, Roswell Park Division, and completed a postdoctoral fellowship at Indiana University School of Medicine.

LinkedIn ↗

Invests in

Biotech

Experience

  1. Codiak BioSciencesCEO
  2. Codiak BioSciencesPresident & CEOcurrent2015 — presentCambridge, MA
  3. BiogenExecutive Vice President Research & Development2011 — 2015Cambridge, MA
  4. ZymoGeneticsCEO2009 — 2010Seattle, WA
  5. ZymoGeneticsPresident & Chief Scientific Officer2007 — 2008Seattle, WA
  6. ZymoGeneticsExecutive Vice President, Research & Development & Chief Scientific Officer2004 — 2007Seattle, WA
  7. Seattle GeneticsExecutive Vice President, Research & Development & Chief Scientific Officer2003 — 2004Bothell, WA
  8. Genesis Research & Development Corp, LtdHead of Health and Strategic Development2002 — 2003Auckland, Auckland, New Zealand
  9. Amgen WashingtonSenior Vice President2002Seattle, WA
  10. Immunex CorporationExecutive Vice President & Chief Technology Officer1999 — 2002Seattle, WA
  11. Immunex CorporationSenior Vice President, Discovery Research1994 — 1999Seattle, WA
  12. Immunex Research & Development Corp.Vice President1992 — 1994Seattle, WA
  13. Immunex Research & Development CorpDirector1989 — 1991Seattle, WA
  14. Immunex Research & Development CorpStaff Scientist1988Seattle, WA

Education

  1. Indiana University School of MedicinePostdoctoral Fellow, Division of Hematology/Oncology1984 — 1987
  2. University at Buffalo Pharmacy and Pharmaceutical SciencesPh.D.1980 — 1984
  3. Greenfield Community CollegeAssociates Degree, Liberal Arts and Sciences/Liberal Studies1976 — 1978
  4. University of Massachusetts LowellBachelor's of Science, Magna Cum Laude Department of Biological Sciences

Same school

Also attended Indiana University School of Medicine3

Eric BeierPartner and Chief Medical Officer at Boomerang VenturesTom MatherManaging Partner at OphthaFundIvor HornInvestor at Seae Ventures

Also attended University at Buffalo Pharmacy and Pharmaceutical Sciences1

David H. CreanGeneral Partner at 1004 Venture Partners

Shared employers

Also worked at Biogen26

Jigar RaythathaInvestor at Third Rock VenturesKevin StarrInvestor at Third Rock VenturesRichard RansohoffVenture Partner at Third Rock VenturesIsaiah Baril-DoreInvestor at Index VenturesSteve HoltzmanBio Advisor at Amplify PartnersRoy LobbVenture Partner at Advent Life Sciences

+ 20 more

Also worked at ZymoGenetics1

James (Jamie) W. BaumgartnerAdvisor at Golden Eagle

Also worked at Seattle Genetics3

Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Louis BockVenture Partner at Sante VenturesDr. Guy PadburySVP, Oncology Clinical Pharmacology at Illinois Ventures

Investments

Board seats

AC Immune SAStablix

Per the firm's website.

Colleagues at Pillar VC

Alec Nielsen
Founder & CEO, Asimov & Venture Partner at Pillar VC
Alex Reinhart
Associate at Pillar VC
Alex Ting
Director of Events & Operations at Pillar VC
Andras Forgacs
Co-Founder & Board Director, Modern Meadow, Fork & Goode, Organovo & Founding Pillar at Pillar VC
Andy Beck
CEO, PathAI & Founding Pillar at Pillar VC
Ash Ashutosh
CEO, Actifio & Founding Pillar at Pillar VC
Bernhard van Lengerich
CEO at Seeding The Future Foundation. Board Member at Beyond Meat and CSO at General Mills & Founding Pillar at Pillar VC
Bill Brady
CEO, Kula Bio, Monolith Materials, Mascoma Corporation & Founding Pillar at Pillar VC